CDK4 is a well‐known oncogene in GBM, and in one of the landmark studies, CDK4 was found to be the second most amplified gene in GBM after EGFR, and this focal amplification eventually leads to its high expression in GBM (Bartel, 2004, 2008). Here, CDK4 is linked to glioblastoma.